))
Nirsevimab: Prevent RSV or Let it Be?
Manage episode 397350750 series 2908322
Content provided by Mayo Clinic. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mayo Clinic or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Kimberly James, PharmD shares developments on respiratory syncytial virus (RSV) prevention in infants.
For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes.
You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
101 episodes
Share
